C4 Therapeutics, Inc.·4

Jan 5, 4:10 PM ET

GROGAN DONNA ROY 4

4 · C4 Therapeutics, Inc. · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Transactions
  • Award

    Common Stock

    2026-01-02$1.93/sh+7,513$14,50066,142 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026.

Documents

1 file
  • 4
    wk-form4_1767647408.xmlPrimary

    FORM 4